Search clinical trials for: Naltrexone

Total 451 results

Alza Corporation, DE, USA

Completed

An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg

Analgesia
AgelessRx

Completed

Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome

Covid19 | Post-COVID-19 Syndrome | Long COVID-19

United States
Orexigen Therapeutics, Inc

Terminated

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

United States
VA Connecticut Healthcare System

Completed

Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Major Depressive Disorder | Alcohol Use Disorder
Brigham and Women's Hospital
Open Medicine Foundation

Not yet recruiting

LIFT: Life Improvement Trial (LIFT)

ME/CFS
Ensysce Biosciences
PRA Health Sciences

Completed

Evaluation of Oral PF614 Relative to OxyContin

Healthy Volunteers

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
Alza Corporation, DE, USA

Completed

Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers

Biological Availability
University of Pennsylvania
National Institute of Drug Abuse; The Wistar Institute; Ho Chi Minh City CDC; Institute...

Recruiting

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 (AMOHI-1)

Inflammation | Opioid-use Disorder | HIV-1-infection | Immune Activation | Buprenorphine | Methadone | Naltrexone | Antiretroviral Treatment

United States, Vietnam
East Carolina University

Completed

Trial of Naltrexone and Dextromethorphan for Gulf War Illness (GWI Treatment)

Gulf War Illness

United States
US Department of Veterans Affairs

Completed

Naltrexone and Patch for Smokers

Smoking

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Sertraline and Naltrexone for Alcohol Dependence

Alcoholism

United States
University of Pennsylvania

Completed

Sertraline for Alcohol Dependence and Depression

Depression | Alcoholism

United States
Pfizer

Completed

Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)

Healthy

Canada
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)

Alcohol Dependence | Alcoholism

United States
The University of Texas Health Science Center,...
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)

Smoking | Alcoholism

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Binge-Eating Disorder

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Breast Cancer Research Foundation; American Institute for Cancer Research; Hopkins-WellSpan...

Active, not recruiting

Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study (A-NEW)

Breast Cancer | Overweight or Obesity

United States
NYU Langone Health
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Opioid Use Disorder (OUD)

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Improving Treatment Outcomes for Prescription Opioid Dependence (GBN)

Drug Dependence

United States
Purdue Pharma LP

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

ECG Effects

United States
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin (UH3)

HIV Infections | Chronic Pain | Alcohol Use, Unspecified

Russian Federation
The Taub Group

Completed

The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression

Depression

United States
Stanford University
National Institute of Mental Health (NIMH)

Recruiting

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2) (MKET2)

Obsessive-Compulsive Disorder

United States
MetroHealth Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV

Cardiovascular Diseases | HIV Infection | Opioid-use Disorder

United States
Annette C. Toledano MD

Completed

Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain

Lower Back Pain | Back Pain | Cervical Pain

United States
Seattle Institute for Biomedical and Clinical Research
United States Department of Defense; VA Puget Sound Health Care System

Completed

Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders (PaN)

Alcohol Use Disorder | Posttraumatic Stress Disorder (PTSD)

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone

Alcohol Dependence

United States
Spark Biomedical, Inc.
Hazelden Betty Ford Foundation; Gaudenzia, Inc.

Recruiting

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE)

Opioid-use Disorder | Opioid Withdrawal

United States
Denver Health and Hospital Authority

Completed

Inpatient Single Dose Interventions for Alcohol Use Disorder

Alcohol Use Disorder, Severe

United States
University of California, Los Angeles

Withdrawn

Relapse Prevention in Stimulant Use Disorder

ADHD | Cognitive Function | Relapse | Stimulant Use

United States
St. Joseph's Healthcare Hamilton
Bausch Health, Canada Inc.

Active, not recruiting

A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery (COR-WR)

Obesity

Canada
Orexigen Therapeutics, Inc

Completed

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

Healthy

United States
Orexigen Therapeutics, Inc

Completed

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Obesity | Overweight

United States
Bankole Johnson
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Combined Pharmacotherapies for Alcoholism

Alcoholism

United States
St. Joseph's Healthcare Hamilton
Bausch Health, Canada Inc.

Active, not recruiting

Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program. (COR-WM)

Obesity

Canada
Pharnext S.C.A.
Worldwide Clinical Trials

Active, not recruiting

Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PREMIER)

Charcot-Marie-Tooth Disease

United States, Spain, Belgium, Italy, Israel, Canada, Denmark, France, Germany
Yale University

Terminated

Promoting Medications for Alcohol Use Disorder on the General Medicine Service

Alcohol Use Disorder

United States
Allodynic Therapeutics, LLC

Completed

Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea

Migraine With and Without Aura

United States
National Institute of Mental Health (NIMH)

Completed

Effects of Yohimbine and Naltrexone on Sexual Function

Erectile Dysfunction

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)

Alcoholism

United States
University of California, San Francisco

Completed

Naltrexone Effects on Alcohol Intake

Social Drinker

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion

Alcohol Dependence | Alcoholism

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 5 - 5

Opioid-Related Disorders

United States
Central Institute of Mental Health, Mannheim

Terminated

Naltrexone in Borderline Personality Disorder

Borderline Personality Disorder

Germany
Centre for Addiction and Mental Health

Completed

Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling

Concurrent Alcohol Dependence and Pathological Gambling

Canada, Finland
National Institute on Drug Abuse (NIDA)

Completed

Naltrexone Augmentation of Nicotine Patch Therapy - 1

Tobacco Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 4 - 4

Opioid-Related Disorders

United States
Sheba Medical Center

Completed

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

Obsessive Compulsive Disorder

Israel
California Pacific Medical Center Research Institute

Completed

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects (AIKO-150)

Opiate Addiction

United States

Search clinical trials for: Naltrexone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations